Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy
Authors:
- Tatjana S. PotparaTPTatjana S. Potpara
- Vera JokicVJVera Jokic
- Nikolaos DagresNDNikolaos Dagres
- Francisco MarinFMFrancisco Marin
- Milica S. ProstranMPMilica S. Prostran
- Carina Blomstrom-LundqvistCBCarina Blomstrom-Lundqvist
- Gregory Y.H. LipGLGregory Y.H. Lip
- 19 July 2016
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 23 (19) , 2070-2083
Abstract
The kidney has numerous complex interactions with the heart, including shared risk factors (e.g., hypertension, dyslipidemia, etc.) and mutual amplification of morbidity and mortality. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various alterations in cardiovascular system, metabolic homeostasis and autonomic nervous system that may facilitate the occurrence of cardiac arrhythmias. Also, pre-existent or incident cardiac arrhythmias such as atrial fibrillation (AF) may accelerate the progression of CKD. Patients with CKD may experience various cardiac rhythm disturbances including sudden cardiac death. Contemporary management of cardiac arrhythmias includes the use of antiarrhythmic drugs (AADs), catheter ablation and cardiac implantable electronic devices (CIEDs). Importantly, AADs are not used only as the principal treatment strategy, but also as an adjunct therapy in combination with CIEDs, to facilitate their effects or to minimize inappropriate device activation in selected patients. Along with their principal antiarrhythmic effect, AADs may also induce cardiac arrhythmias and the risk for such proarrhythmic effect(s) is particularly increased in patients with reduced left ventricular systolic function or in the setting of electrolyte imbalance. Moreover, CKD itself can induce profound alterations in the pharmacokinetics and pharmacodynamics of many drugs including AADs, thus facilitating the drug accumulation and increased exposure. Hence, the use of AADs in patients with CKD may be challenging. In this review article, we provide an overview of the characteristics of arrhythmogenesis in patients with CKD with special emphasis on the complexity of pharmacokinetics and risk for proarrhythmias when using AADs in patients with cardiac arrhythmias and CKD.Keywords
This publication has 75 references indexed in Scilit:
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationCochrane Database of Systematic Reviews, 2015
- Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: Results from the American College of Cardiology’s NCDR®American Heart Journal, 2011
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)American Heart Journal, 2010
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine studyAmerican Heart Journal, 2009
- Prognostic Significance of Increased Left Ventricular Mass Index to Mortality and Sudden Death in Patients With Stable Coronary Heart Disease (from the Heart and Soul Study)The American Journal of Cardiology, 2008
- Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) studyAmerican Heart Journal, 2008
- High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE DatabaseJournal of Cardiac Failure, 2007
- The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patientsAmerican Heart Journal, 2006
- Relations Among Renal Function, Risk of Sudden Cardiac Death, and Benefit of the Implanted Cardiac Defibrillator in Patients With Ischemic Left Ventricular DysfunctionThe American Journal of Cardiology, 2006
- Hepatic drug metabolism and transport in patients with kidney diseaseAmerican Journal of Kidney Diseases, 2003